CEO sold ~$2.43M of Quest Diagnostics
Scheduled in advanceLoading…
Transaction Oct 30, 2025 · Disclosed Aug 5, 2026
Held by the filer's joint per the disclosure. Disclosed 279 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$1,001 - $15,000
Official band as filed. No midpoint or exact amount is implied
Joint
279 days
Days between the transaction date and the filing date
First disclosure on this company by this filer
No other filers within 90 days
Sponsored 5 bills in Health this Congress.
Bills (H.R. / S.) this member sponsored in the 119th Congress so far, including any introduced after the trade, grouped by the policy area the Congressional Research Service assigned (Congress.gov). Which policy areas relate to which sectors is OQRO's editorial mapping. Not a sign of what they knew or why they traded
CEO sold ~$2.43M of Quest Diagnostics
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Officer sold ~$3.89M of Quest Diagnostics
Scheduled in advance
